SUN PHARMACEUTICAL INDUSTRIES INC FDA Inspection Record
SUN PHARMACEUTICAL INDUSTRIES INC is an FDA-inspected facility (FEI 3013472760) located in Princeton, NJ, US. RegDataLab tracks 13 FDA inspections and 1 compliance action at this facility.
What FDA found at this site
- Latest inspection
- Dec 12, 2024: No Action Indicated (NAI)
- Inspections on record
- 13 (1 OAI, 5 VAI, 7 NAI)
- Last OAI inspection
- Apr 28, 2010
- Warning letters
- 1 listed by FDA for this FEI, latest Aug 25, 2010
- Recalls as the recalling firm
- 71, latest Oct 21, 2026
- Import refusals
- 1
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Dec 12, 2024 | No Action Indicated (NAI) | No citations listed |
| Aug 10, 2022 | No Action Indicated (NAI) | No citations listed |
| Mar 8, 2019 | No Action Indicated (NAI) | No citations listed |
| Sep 18, 2018 | No Action Indicated (NAI) | No citations listed |
| Mar 9, 2018 | Voluntary Action Indicated (VAI) | Procedures not in writing, fully followed (21 CFR 211.22(d)) Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a)) Calibration/Inspection/Checking not done (21 CFR 211.68(a)) Packaging line inspection after use (21 CFR 211.130(e)) and 4 more |
| Mar 20, 2017 | Voluntary Action Indicated (VAI) | Identification of Persons Performing Significant Steps (21 CFR 211.188(b)(11)) |
| Nov 20, 2015 | No Action Indicated (NAI) | No citations listed |
| Aug 27, 2015 | Voluntary Action Indicated (VAI) | Late submission of 15-day report (21 CFR 314.80(c)(1)(i)) Submission of report follow-up (21 CFR 314.80(c)(1)(ii)) |
| Jul 15, 2015 | Voluntary Action Indicated (VAI) | No citations listed |
| May 16, 2013 | Voluntary Action Indicated (VAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Oct 21, 2026 | Class II | D-0174-2027 | Lisdexamfetamine Dimesylate Capsules 40 mg, 100-count bottle, Rx Only, Manufactured by… Failed Dissolution Specifications |
| Sep 25, 2026 | Class III | D-0033-2027 | Tretinoin Cream USP, 0.05%, 45g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc… and 2 more products Failed Impurities/Degradation Specifications |
| Sep 14, 2026 | Class II | D-0872-2026 | Nystatin Cream, USP, 100,000 units/g, 15 g (NDC 51672-1289-1) and 30 g (NDC 51672-1289-2)… Failed Stability Specifications |
| Aug 3, 2026 | Class II | D-0770-2026 | Carbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro… CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing |
| Jun 17, 2026 | Class II | D-0628-2026 | Perampanel CIII Tablets, 6mg, Rx only, 30 Tablets, Mfd.by: Taro Pharmaceutical Industries… Labeling: Label Mix-up: Bottle labeled Perampanel 6 mg tablets contained 10mg Perampanel CIII tablets |
| Jun 1, 2026 | Class III | D-0654-2026 | Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle… Failed Impurities/Degradation Specifications |
| May 29, 2026 | Class II | D-0607-2026 | Budesonide Inhalation Suspension, 1mg/2mL, 30 x 2 mL Sterile Single-Dose Ampules (5… Presence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and… |
| May 22, 2026 | Class II | D-0598-2026 | Xyvona (levorphanol tartrate tablets), 2mg, 100 Tablets, Rx only, Forte BioPharma… and 1 more product Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the… |
| May 12, 2026 | Class I | D-0580-2026 | DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials… Presence of Particulate matter: Particulate matter identified as glass. |
| Mar 25, 2026 | Class II | D-0475-2026 | Fluocinonide, USP, 0.05% Cream, 15g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc… and 2 more products Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing. |
FDA record score
100 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. The records below add up to 139; the score stops at 100.
55 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Class I recall D-0580-2026, this FEI as the recalling firm | May 12, 2026 | 15 x 1 | 15 |
| Class II recall D-0174-2027, this FEI as the recalling firm | Oct 21, 2026 | 4 x 1 | 4 |
| Class II recall D-0872-2026, this FEI as the recalling firm | Sep 14, 2026 | 4 x 1 | 4 |
| Class II recall D-0770-2026, this FEI as the recalling firm | Aug 3, 2026 | 4 x 1 | 4 |
| Class II recall D-0628-2026, this FEI as the recalling firm | Jun 17, 2026 | 4 x 1 | 4 |
| Class II recall D-0607-2026, this FEI as the recalling firm | May 29, 2026 | 4 x 1 | 4 |
| Class II recall D-0598-2026, this FEI as the recalling firm | May 22, 2026 | 4 x 1 | 4 |
| Class II recall D-0475-2026, this FEI as the recalling firm | Mar 25, 2026 | 4 x 1 | 4 |
| Class II recall D-0342-2026, this FEI as the recalling firm | Jan 27, 2026 | 4 x 1 | 4 |
| Class II recall D-0144-2026, this FEI as the recalling firm | Oct 28, 2025 | 4 x 1 | 4 |
| Class II recall D-0658-2025, this FEI as the recalling firm | Sep 3, 2025 | 4 x 1 | 4 |
| Class II recall D-0574-2025, this FEI as the recalling firm | Aug 5, 2025 | 4 x 1 | 4 |
| Class II recall D-0516-2025, this FEI as the recalling firm | Jun 16, 2025 | 4 x 1 | 4 |
| Class II recall D-0249-2025, this FEI as the recalling firm | Feb 6, 2025 | 4 x 1 | 4 |
| Class II recall D-0597-2024, this FEI as the recalling firm | Jul 9, 2024 | 4 x 0.6 | 2.4 |
| Class II recall D-0582-2024, this FEI as the recalling firm | Jul 2, 2024 | 4 x 0.6 | 2.4 |
| Class II recall D-0493-2024, this FEI as the recalling firm | Apr 19, 2024 | 4 x 0.6 | 2.4 |
| Class II recall D-0368-2024, this FEI as the recalling firm | Mar 4, 2024 | 4 x 0.6 | 2.4 |
| Class II recall D-0350-2024, this FEI as the recalling firm | Feb 5, 2024 | 4 x 0.6 | 2.4 |
| Class II recall D-0263-2024, this FEI as the recalling firm | Jan 18, 2024 | 4 x 0.6 | 2.4 |
| Class II recall D-0150-2024, this FEI as the recalling firm | Dec 4, 2023 | 4 x 0.6 | 2.4 |
| Class II recall D-0083-2024, this FEI as the recalling firm | Oct 20, 2023 | 4 x 0.6 | 2.4 |
| Class II recall D-0940-2023, this FEI as the recalling firm | Jul 13, 2023 | 4 x 0.6 | 2.4 |
| Class II recall D-0914-2023, this FEI as the recalling firm | Jul 10, 2023 | 4 x 0.6 | 2.4 |
| Class II recall D-0891-2023, this FEI as the recalling firm | May 30, 2023 | 4 x 0.6 | 2.4 |
| Class II recall D-0761-2023, this FEI as the recalling firm | May 9, 2023 | 4 x 0.6 | 2.4 |
| Class II recall D-0869-2023, this FEI as the recalling firm | May 3, 2023 | 4 x 0.6 | 2.4 |
| Class II recall D-0262-2023, this FEI as the recalling firm | Jan 13, 2023 | 4 x 0.6 | 2.4 |
| Class II recall D-0085-2023, this FEI as the recalling firm | Dec 1, 2022 | 4 x 0.6 | 2.4 |
| Class II recall D-0024-2023, this FEI as the recalling firm | Oct 18, 2022 | 4 x 0.6 | 2.4 |
| Class II recall D-0068-2023, this FEI as the recalling firm | Jul 25, 2022 | 4 x 0.6 | 2.4 |
| Class II recall D-1291-2022, this FEI as the recalling firm | Jun 27, 2022 | 4 x 0.6 | 2.4 |
| Class II recall D-1190-2022, this FEI as the recalling firm | Jun 21, 2022 | 4 x 0.6 | 2.4 |
| Class II recall D-1154-2022, this FEI as the recalling firm | Jun 10, 2022 | 4 x 0.6 | 2.4 |
| Class II recall D-1153-2022, this FEI as the recalling firm | Jun 3, 2022 | 4 x 0.6 | 2.4 |
| Class II recall D-1155-2022, this FEI as the recalling firm | Jun 3, 2022 | 4 x 0.6 | 2.4 |
| Class II recall D-1176-2022, this FEI as the recalling firm | Jun 3, 2022 | 4 x 0.6 | 2.4 |
| Class II recall D-1143-2022, this FEI as the recalling firm | May 6, 2022 | 4 x 0.6 | 2.4 |
| Class II recall D-0578-2022, this FEI as the recalling firm | Feb 7, 2022 | 4 x 0.6 | 2.4 |
| Inspection classified VAI | Mar 9, 2018 | 6 x 0.25 | 1.5 |
| Inspection classified VAI | Mar 20, 2017 | 6 x 0.25 | 1.5 |
| Class II recall D-0230-2022, this FEI as the recalling firm | Oct 25, 2021 | 4 x 0.25 | 1 |
| Class II recall D-0361-2022, this FEI as the recalling firm | Oct 22, 2021 | 4 x 0.25 | 1 |
| Class II recall D-0703-2021, this FEI as the recalling firm | Jul 29, 2021 | 4 x 0.25 | 1 |
| Class II recall D-0372-2021, this FEI as the recalling firm | May 4, 2021 | 4 x 0.25 | 1 |
| Class II recall D-0334-2021, this FEI as the recalling firm | Mar 31, 2021 | 4 x 0.25 | 1 |
| Class II recall D-0320-2021, this FEI as the recalling firm | Mar 15, 2021 | 4 x 0.25 | 1 |
| Class II recall D-0002-2021, this FEI as the recalling firm | Sep 23, 2020 | 4 x 0.25 | 1 |
| Class II recall D-0787-2020, this FEI as the recalling firm | Jan 14, 2020 | 4 x 0.25 | 1 |
| Class II recall D-0659-2020, this FEI as the recalling firm | Dec 26, 2019 | 4 x 0.25 | 1 |
| Inspection classified VAI | Aug 27, 2015 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Jul 15, 2015 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | May 16, 2013 | 10 years or older, so it adds no points | 0 |
| Warning letter on FDA's dashboard, which does not show close-outs | Aug 25, 2010 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | Apr 28, 2010 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing SUN PHARMACEUTICAL INDUSTRIES INC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check SUN PHARMACEUTICAL INDUSTRIES INC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- SUN PHARMACEUTICAL INDUSTRIES INC
- Location
- Princeton, NJ (US)
- Source
- inspections